Severe opioid withdrawal, risk of patient-initiated discharge, and some inpatients’ use of unregulated substances prompt clinical and ethical questions considered in this commentary on a case. Short-acting opioids can be used to manage inpatients’ pain and opioid use disorder (OUD)…
Practices and interventions that aim to slow progression or reduce negative consequences of substance use are harm reduction strategies. Often described as a form of tertiary prevention, harm reduction is key to caring well for people who use drugs. Evidence-based…
Overall rates of opioid use are low in adolescents; however, recent increases in mortality from overdose in adolescents have outpaced increases in the general population. This article highlights the importance of expanding evidence-based treatment for adolescent opioid use, especially medication,…
This activity is comprised of five multiple-choice questions based on the content of an AMA Journal of Ethics podcast about how street outreach programs help mitigate harms of drug use among people experiencing homelessness. The featured guest are Dave Lettrich,…
Medical-legal partnership (MLP) integrates the unique expertise of lawyers into collaborative clinical environments. MLP teams meet the needs of individual patients while also detecting structural problems at the root of health inequities and advancing solutions at the institutional, community, and…
Medical-legal partnerships vary widely in how they are structured and use data to inform service delivery. Epidemiological data on certain chronic conditions’ prevalence, the incidence of potentially preventable morbidity, and health-harming legal factors also influence approaches to care. This article…
This case commentary considers unique features of medical-legal partnerships (MLPs) in the Veterans Health Administration that may potentially mediate and minimize ethical tensions that may arise in MLP collaborations involving diagnosing and documenting disability.
This activity is comprised of five multiple-choice questions based on the content of an AMA Journal of Ethics podcast about how medical-legal partnerships can help undocumented patient-clients. The featured guest is Lynette Martins, a legal and bioethics scholar. The target…
Historically, most discussions about nonhuman animal experimentation consider what has become known as the 3 R’s: refinement, reduction, and replacement. Refinement and reduction receive the most attention, but recent modeling advances suggest that suitable replacement of nonhuman animal testing would…
This article reviews the design of a recently published randomized controlled trial (RCT) on immediate vs delayed access to gender-affirming hormones for transgender and gender-diverse (TGD) people and outlines key learning points that clinicians should know about how RCTs can…
© 2026
American Board of Medical Specialties | Policies | Sitemap | Terms of Use | www.abms.org
